416 related articles for article (PubMed ID: 26400304)
21. [Relation between DNA content in ovarian cystadenoma and its pathohistology].
Sun ZC
Zhonghua Fu Chan Ke Za Zhi; 1993 Dec; 28(12):731-3, 760-1. PubMed ID: 8137645
[TBL] [Abstract][Full Text] [Related]
22. KRAS mutation testing in borderline ovarian tumors and low-grade ovarian carcinomas with a rapid, fully integrated molecular diagnostic system.
Sadlecki P; Antosik P; Grzanka D; Grabiec M; Walentowicz-Sadlecka M
Tumour Biol; 2017 Oct; 39(10):1010428317733984. PubMed ID: 28992761
[TBL] [Abstract][Full Text] [Related]
23. Pre-invasive ovarian mucinous tumors are characterized by CDKN2A and RAS pathway aberrations.
Hunter SM; Gorringe KL; Christie M; Rowley SM; Bowtell DD; ; Campbell IG
Clin Cancer Res; 2012 Oct; 18(19):5267-77. PubMed ID: 22891197
[TBL] [Abstract][Full Text] [Related]
24. [Correlation of hK6 expression with clinicopathological features and prognosis in epithelial ovarian cancer].
Hu CJ; Zhang F; Chen YJ; Sun XM; Zheng JF
Zhonghua Zhong Liu Za Zhi; 2009 Jul; 31(7):520-3. PubMed ID: 19950700
[TBL] [Abstract][Full Text] [Related]
25. A huge ovarian mucinous cystadenoma in a 14-year-old premenarchal girl: review on ovarian mucinous tumor in premenarchal girls.
Karaman A; Azili MN; Boduroğlu EC; Karaman I; Erdoğan D; Cavuşoğlu YH; Aslan MK; Cakmak O
J Pediatr Adolesc Gynecol; 2008 Feb; 21(1):41-4. PubMed ID: 18312801
[TBL] [Abstract][Full Text] [Related]
26. [Clinicopathologic analysis and expression of cyclin D1 and p53 of ovarian borderline tumors and carcinomas].
Shao HL; Shen DH; Xue WC; Li Y; Yu YZ
Zhonghua Fu Chan Ke Za Zhi; 2007 Apr; 42(4):227-32. PubMed ID: 17631760
[TBL] [Abstract][Full Text] [Related]
27. Primary ovarian mucinous tumors with signet ring cells: report of 3 cases with discussion of so-called primary Krukenberg tumor.
McCluggage WG; Young RH
Am J Surg Pathol; 2008 Sep; 32(9):1373-9. PubMed ID: 18670351
[TBL] [Abstract][Full Text] [Related]
28. Simultaneous mucinous cystadenoma of ovary and mucinous cystadenocarcinoma of pancreas.
Gagne LJ; Colacchio T; Longnecker DS
Int J Pancreatol; 2000 Aug; 28(1):9-13. PubMed ID: 11185714
[TBL] [Abstract][Full Text] [Related]
29. [Neuroendocrine differentiation in ovarian mucinous tumors].
Jiang C; Tan Y; Li E
Zhonghua Bing Li Xue Za Zhi; 1998 Apr; 27(2):130-3. PubMed ID: 11244965
[TBL] [Abstract][Full Text] [Related]
30. Mucin gene transcripts in benign and borderline mucinous tumours of the ovary: an in situ hybridization study.
Boman F; Buisine MP; Wacrenier A; Querleu D; Aubert JP; Porchet N
J Pathol; 2001 Mar; 193(3):339-44. PubMed ID: 11241413
[TBL] [Abstract][Full Text] [Related]
31. Expression of hepatocyte nuclear factor 4 alpha in primary ovarian mucinous tumors.
Sugai M; Umezu H; Yamamoto T; Jiang S; Iwanari H; Tanaka T; Hamakubo T; Kodama T; Naito M
Pathol Int; 2008 Nov; 58(11):681-6. PubMed ID: 18844932
[TBL] [Abstract][Full Text] [Related]
32. [Expression of mesothelin mRNA and protein in ovarian carcinomas].
Bi SN; Dai SZ; Yao Q; Che YC; Wang N
Zhonghua Zhong Liu Za Zhi; 2008 Apr; 30(4):288-91. PubMed ID: 18788634
[TBL] [Abstract][Full Text] [Related]
33. Germline fumarate hydratase mutations in patients with ovarian mucinous cystadenoma.
Ylisaukko-oja SK; Cybulski C; Lehtonen R; Kiuru M; Matyjasik J; Szymañska A; Szymañska-Pasternak J; Dyrskjot L; Butzow R; Orntoft TF; Launonen V; Lubiñski J; Aaltonen LA
Eur J Hum Genet; 2006 Jul; 14(7):880-3. PubMed ID: 16639410
[TBL] [Abstract][Full Text] [Related]
34. Ovarian intestinal-type mucinous borderline tumors: a nomenclature change is long overdue.
Kurman RJ; Ronnett BM
Int J Gynecol Pathol; 2010 Nov; 29(6):552-3; author reply 553-4. PubMed ID: 20881857
[No Abstract] [Full Text] [Related]
35. [Mucinous tumors of the ovary. Anatomo-clinical aspects, histological classification, prognostic factors and histogenesis].
Bouzourene H; Genton CY
Arch Anat Cytol Pathol; 1997; 45(4):192-8. PubMed ID: 9406476
[TBL] [Abstract][Full Text] [Related]
36. [Accuracy of frozen section in diagnosis of ovarian tumors].
Zhang GN
Zhonghua Fu Chan Ke Za Zhi; 1993 Oct; 28(10):601-3, 635. PubMed ID: 8112130
[TBL] [Abstract][Full Text] [Related]
37. Mucinous borderline ovarian tumors: points of general agreement and persistent controversies regarding nomenclature, diagnostic criteria, and behavior.
Ronnett BM; Kajdacsy-Balla A; Gilks CB; Merino MJ; Silva E; Werness BA; Young RH
Hum Pathol; 2004 Aug; 35(8):949-60. PubMed ID: 15297962
[TBL] [Abstract][Full Text] [Related]
38. [Expression of the cdx2 gene in benign intestinal-type mucinous ovarian tumors].
Gaggero G; Sola S; Mora M; Fulcheri E
Pathologica; 2003 Aug; 95(4):185-91. PubMed ID: 14577202
[TBL] [Abstract][Full Text] [Related]
39. u-PA expression in benign, borderline and malignant ovarian tumors.
Kiziridou AD; Toliou T; Stefanou D; Agnantis N
Anticancer Res; 2002; 22(2A):985-90. PubMed ID: 12014682
[TBL] [Abstract][Full Text] [Related]
40. [Expression and significance of Survivin and Smac in ovarian mucinous tumors].
Wang HX; Chen G; Li GL; Jiang YJ
Zhonghua Bing Li Xue Za Zhi; 2010 Jun; 39(6):387-90. PubMed ID: 21055155
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
